RLS (Rayls) fluctuated by 41.6% in 24 hours: trading volume surged 251%, triggering speculative price volatility
Bitget Pulse2026/04/14 23:12Volatility Brief
In the past 24 hours, the price of RLS rebounded from a low of $0.00243 to a high of $0.00344, currently quoted at $0.00282, showing a fluctuation range of 41.6%. Trading volume has surged significantly to about $4.99 million (CoinGecko data, up 251.4% from the previous day), with CoinMarketCap showing an even higher figure of $7.83 million; on-chain net outflow is about $1,361, and CEX net outflow is $1,152.
Brief Analysis of the Cause of the Fluctuation
- Trading volume skyrocketed 251.4% to nearly $5 million, which is the main driving force, accompanied by multiple intraday price spikes and pullbacks (such as Coinbase spot +6.72% in 60 minutes, then -3.54%).
- There have been no official announcements, listings, or large whale transactions in the past 24 hours; on-chain CEX/DEX net outflows indicate capital outflow pressure.
Market Views and Outlook
The trading community is active, with multiple accounts like Finora AI publishing short-term support/resistance signals (e.g., the $0.00224–$0.00263 range). CoinGecko community sentiment is 88% bullish, but warns of overbought RSI (peaked at 85) and possible pullback risks. Overall, RLS lags behind the broader crypto market (+4.1%). Going forward, watch for the mainnet launch on April 30th.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cyclical stocks always peak when they're “cheapest” — Citrini, the “chip influencer” who was the earliest to be bullish on AI hardware, is now quietly exiting
Citrini, once the most prominent bull in AI hardware, has now significantly reduced his semiconductor holdings and currently holds some short positions. He believes that the financing structure for AI infrastructure has shifted from tech giants' own cash flows to equity and debt markets, and that sentiment alone could sever the funding chain and impact fundamentals. Strategically, he is long Meta and short Google. Citrini also asserts that the bottleneck in AI pharmaceutical development is not computational power, but rather a "lack of monkeys."
New Zealand Dollar gains ground to near 0.5700 as RBNZ rate hike bets rise
Median survival prolonged by 5.7 months! Roche (RHHBY.US) lung cancer new drug wins in head-to-head trial, major catalyst for oncology business
Roche's investigational lung cancer drug divarasib extended patient survival by nearly six months compared to competing therapies in a late-stage clinical trial, promising to further strengthen the Swiss pharmaceutical company's oncology portfolio.
Global Aging Reshapes Equity and Bond Investment Logic? Pension "Longevity Bill" Accelerates Accumulation, Equities, Bonds, and Private Equity Welcome Massive Long-term Capital
As people live longer and birth rates decline, pension funds are required to allocate their assets for retirement periods that can last decades. Meanwhile, the number of workers contributing to these systems is decreasing.
Crypto prices
More
